NCT07038447 A Study of KITE-363 in Participants With Refractory Autoimmune Diseases Status ENROLLING_BY_INVITATION Phase PHASE1
NCT07031674 Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study. Status COMPLETED Phase N/A
NCT07015983 A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06925542 A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease Status RECRUITING Phase PHASE1
NCT06904729 Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children Status RECRUITING Phase PHASE3
NCT06796569 Systemic Immune Inflammatory Index in Systemic Lupus Erythematosus Status RECRUITING Phase N/A
NCT06785519 CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis Status RECRUITING Phase EARLY_PHASE1
NCT06752876 CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP) Status WITHDRAWN Phase PHASE1
NCT06717815 Phase IIa Study for IPG11406 in Patients With Lupus Nephritis Status RECRUITING Phase PHASE1/PHASE2
NCT06711887 Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension) Status RECRUITING Phase PHASE3
NCT06681337 Universal CAR-T Cell Therapy for Refractory Lupus Nephritis Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06631404 Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients Status RECRUITING Phase N/A
NCT06610422 Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients Status NOT_YET_RECRUITING Phase N/A
NCT06581198 A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN) Status RECRUITING Phase PHASE2
NCT06557265 A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) Status RECRUITING Phase PHASE1/PHASE2
NCT06544330 A Phase 1 Study of SYNCAR-001 + STK-009 Without Conditioning Chemotherapy (Lymphodepletion) in Subjects With Severe, Refractory Systemic Autoimmune Rheumatic Disease Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06527872 Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN Status RECRUITING Phase N/A